Navin Fluorine to Meet Investors on Feb 24-25, 2026; Q3FY26 Results Show Strong Growth
Navin Fluorine will interact with investors on Feb 24-25, 2026. Q3FY26 consolidated sales rose 47% YoY to ₹892.4 crore, with Operating EBITDA up 109% YoY to ₹307.6 crore. 9MFY26 sales increased 44% YoY to ₹2,376.2 crore. Key capex includes ₹236.5 crore for HFC capacity by Q3FY27.
The announcement includes both an investor engagement event and robust financial performance, which are key drivers for investor interest and stock valuation. The significant growth figures and strategic capex plans are material information for stakeholders.
The company is announcing investor meetings and simultaneously reporting strong financial results with significant year-on-year growth in sales, EBITDA, and PBT across multiple segments. The ongoing capex projects indicate future growth potential.
Navin Fluorine International Limited has announced its schedule for interactions with Analysts and Institutional Investors on February 24 and February 25, 2026. These meetings, which will be conducted physically with Jefferies, will include one-on-one and group sessions.
The company's Q3FY26 results showcased significant growth, with consolidated sales reaching ₹892.4 crore, a year-on-year increase of 47%. Operating EBITDA surged by 109% YoY to ₹307.6 crore, and Operating PBT grew by 149% YoY to ₹243.2 crore. For the first nine months of FY26 (9MFY26), consolidated sales were ₹2,376.2 crore (up 44% YoY), Operating EBITDA was ₹760.5 crore (up 114% YoY), and Operating PBT was ₹563.6 crore (up 155% YoY).
Key capex projects include an additional HFC capacity of up to 15,000 MTPA of R32, expected by Q3FY27 with an investment of ₹236.5 crore. A de-bottlenecking MPP capacity project at Dahej is targeted for Q3FY27 with a capex of ₹75 crore. Additionally, a capex of ₹120 crore is planned for Advanced Materials, with commissioning by Q1FY27.
The company also highlighted its strong performance in Specialty Chemicals, with Q3FY26 revenues up 60% YoY, and in CDMO, with revenues up 61% YoY. The investor presentation, which will form the basis of discussions, is enclosed with this intimation.
What to do with a filing like this
Navin Fluorine International Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Navin Fluorine International Limited. Read the original for the full detail.